Two U.S. companies teamed up to treat cancer patients using an unproven blood filter in Antigua, out of reach of American regulators. Credit...Javier Jaén Supported by By John Carreyrou The private ...
The FDA slammed ExThera with a warning letter for deviating from the regulatory agency’s guidelines by promoting and selling its Seraph 100 blood filter device to treat cancer patients under specious ...
Hosted on MSN
ExThera hit with $5.6M forfeiture after executive concealed deadly blood filter device side effects
A Northern California medical technology firm has been hit with a $5.6 million (£4.19 million) forfeiture order after one of its top executives admitted she concealed patient deaths from the US Food ...
MARTINEZ, Calif.--(BUSINESS WIRE)--A newly published study in Nature’s Scientific Reports finds that use of ExThera’s Seraph ® 100 blood filter in septic patients following cardiac surgery ...
Add Yahoo as a preferred source to see more of our stories on Google. West Nile Virus detected in mosquito test sample from Jamaica Plain An ExThera Medical Corp. executive has agreed to plead guilty ...
The MarketWatch News Department was not involved in the creation of this content. ExThera Has Reached a Resolution with the U.S. Department of Justice, with Substantial Recognition for Cooperating in ...
MARTINEZ, Calif.--(BUSINESS WIRE)--A new laboratory study has provided insights into the potential therapeutic benefits of blood purification for patients with metastatic pancreatic ductal ...
ExThera Medical agrees to $750,000 fine and $5.69 million forfeiture Former executive to plead guilty, faces 34-month prison recommendation Prosecutors said executive concealed from FDA deaths of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results